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Abstract
Purpose Iodine deficiency due to insufficient nutritional intake is a public health challenge in several European countries, 
including Norway. Lean-seafood has a high iodine and arsenic (As) content and is a good source of selenium (Se). Evidence 
of a direct effect of increased intake of lean-seafood on iodine status is limited. The main aims were to determine the iodine 
status at baseline and to investigate possible dietary effects on urinary iodine concentration (UIC) after intervention with 
lean-seafood versus non-seafood. Plasma Se, and plasma and urinary As concentrations were also measured.
Methods A randomized controlled crossover study comprising two 4 weeks experimental periods with two balanced diets 
varied in main proteins (60% of total dietary proteins) of lean-seafood and non-seafood, separated by a 5 week washout 
period.
Results Twenty participants (7 males, 13 females) were included and the mean ± SD age was 50.6 ± 15.3 years for all partici-
pants. Fasting UIC was median (25th, 75th percentile) 70 (38, 110) and 79 (49, 94) µg/L in the lean-seafood and non-seafood 
intervention at baseline, respectively. UIC increased after 4 weeks of the lean-seafood intervention to 135 (110, 278) µg/L, 
but not after the non-seafood intervention [58 (33, 91) µg/L] (P diet-effect < 0.001). Fasting plasma Se increased in the 
lean-seafood intervention and decreased in the non-seafood intervention (P diet-effect = 0.001). Fasting urinary and plasma 
As increased in the lean-seafood intervention and was unchanged in the non-seafood intervention (P diet-effect < 0.001).
Conclusion The participant’s UIC was below the recommended median (100 µg/L) at baseline, but increased sufficiently 
after a 4 week intervention with lean-seafood.
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Introduction
Iodine is essential for thyroid hormone production [1]. Sub-
optimal iodine status is a public health concern worldwide, 
and despite efforts to increase the dietary iodine intake, 
Europe is still the continent with the highest prevalence of 
iodine deficiency [2]. This is a particular concern for women 
that are pregnant and/or at childbearing age [3–7].
Dietary sources of iodine are limited. Hence, to cope 
with iodine insufficiency, iodized salt programmes are rec-
ommended [4, 8]. Such programmes have a high impact 
globally, but several European countries have not fol-
lowed this strategy. The impact of iodized salt in Norway 
is limited as the amount of iodine in the iodized salt is low 
(5 mg iodine/kg salt), and the food industry is not allowed 
to use iodized salt. However, the cow feed has been forti-
fied with iodine since the 1950s. Thus, milk and dairy 
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products are the major sources of iodine in Norway [9, 
10], and contributes with about 55% of the iodine intake 
[11]. Seawater fish and seafood are the food items where 
iodine is occurring at the highest concentrations [10, 12]. 
Although the concentration of iodine is higher in seafood 
than milk and dairy products there is lack of associations 
between intake of seafood and adequate UIC in Danish and 
Icelandic populations [13, 14]. However, a direct effect 
of increased intake of lean-seafood on UIC has to our 
knowledge been demonstrated in one intervention study 
[15]. Unlike iodized salt, intake of lean-seafood will also 
provide other components. Lean-seafood contains undesir-
able substances such as Hg [16], but also essential nutri-
ents, such as selenium (Se), B vitamins, trace elements 
and some long chain n-3 polyunsaturated fatty acids [17]. 
Additionally, lean fish also provide high quality marine 
proteins and taurine [18].
UIC in spot urine samples is the recommended method to 
assess iodine status by World Health Organization (WHO), 
United Nations children’s fund (UNICEF) and Iodine Global 
Network (IGN). Importantly, however, UIC reflects the last 
24 h of iodine intake. Hence, even if seafood is consumed 
2–3 times a week as recommended, associations between 
seafood intake and UIC would necessarily be more diffi-
cult to reveal than associations with intake of items often 
consumed on a daily basis, such as milk and dairy. Thus, 
as lean-seafood is rarely consumed daily and UIC reflects 
the last day of iodine intake, the contribution of seafood for 
maintenance of sufficient iodine status may be underesti-
mated in population-based studies.
To document the effect of lean-seafood on iodine status, 
we measured iodine in urine collected from participants in 
an intervention study, with a crossover design where lean-
seafood was consumed every day and intake of milk and 
dairy were restricted. As lean-seafood also is the main con-
tributor of dietary arsenic (As) and represents an important 
source for Se, we concurrently measured plasma levels of 
Se and As, as well as urinary As.
Materials and methods
Ethics statement
The study was registered at www.Clini calTr ials.gov 
(NCT01708681) and performed in accordance with the 
ethical standards of the regional committee on human 
experimentation. The protocol, informed consent and adver-
tisements were approved by the Regional Committee for 
Medical and Health Research Ethics West, Norway (Refer-
ence # 2012/1084). All subjects signed a written informed 
consent.
Study procedure and participants
This study is based on a previous performed RCT with cross-
over design where the primary outcome was the change in 
fasting and postprandial lipids from pre- to post-intervention 
during the two intervention periods. Experimental design 
and recruitment of participants are earlier described by 
Aadland et al. [19]. The participants were recruited during 
October and November 2012. The 1st intervention period 
was from January to February 2013 and the 2nd intervention 
period from April to May 2013.
Recruitment of participants, inclusion/exclusion crite-
ria and their physical and clinical characteristics have been 
described [19]. Briefly, healthy, non-smoking, male and 
female Caucasian subjects, 18–65 years old were recruited 
in the great area of Bergen, Norway.
Based on data obtained from a pre-study visit [19], 30 
subjects were invited to participate and 27 subjects accepted 
to start. Of these, 20 subjects completed period one (7 men 
and 13 women) and 19 subjects (7 men and 12 women) com-
pleted both periods (Fig. 1). No adverse events were reported 
during or after the intervention.
Outcome measures and power calculation
The primary outcome in this RCT with crossover design was 
the change in fasting and postprandial lipids from pre- to 
post-intervention during the two intervention periods, and 
sample size was calculated based on the efficacy of fish pro-
tein to reduce plasma VLDL-TAG [19] and on the procedure 
described by Wellek and Blettner [20] for crossover design 
in clinical trials. A minimum of 16 subjects was needed to 
detect a treatment difference of ~ 25–30% in plasma VLDL-
TAG at a probability level inferior to 0.05 and a power level 
corresponding to 80%. The primary outcome in the present 
paper was UIC, and secondary outcomes were plasma levels 
of Se and As, as well as urinary As.
Experimental design
As described previously [19], a controlled, randomized 
crossover study comprising two 4 weeks experimental peri-
ods, separated by a 5 week washout period was performed 
(Fig. 2). Prior to study start, the subjects were randomly 
allocated to start with one of the two dietary interventions. 
Randomization was performed by placing 30 pieces of 
papers, each piece with one of the participant’s identifica-
tion number, and in an alternating order assigning the sub-
jects to start with the lean-seafood or non-seafood diet by 
picking the paper pieces sequentially from the box. All par-
ticipants were instructed to follow a diet in accordance with 
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Fig. 1   Consolidated flow chart for recruitment, randomization, and data sampling from the study participants





















Fig. 2   The crossover study design
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the Norwegian dietary recommendations [21] for 3 weeks 
(run-in period), with additional specifications to include a 
maximum of one fatty fish (salmon, trout, mackerel or her-
ring) meal per week prior both experiments periods. During 
the last week of the run-in period and washout periods and 
throughout both experimental periods, the participants were 
instructed to avoid alcohol, chocolate or candy, industrial 
baked cakes or cookies, fast food, probiotics, and fish or 
fish oil supplements. They were also instructed to maintain 
their normal physical activity level during the run-in, experi-
mental and washout periods. Fourteen subjects (6 men and 
8 women) assigned to the lean-seafood diet consisting of 
lunch- and dinner meals with the 1st experimental period, 
whereas 13 subjects (4 men and 9 women) were assigned 
to a non-seafood diet. Compliance was assessed daily by an 
oral questionnaire. Only minor deviations occurred. Body 
mass was monitored and if necessary, dietary energy level 
adjusted to maintain a stable body weight (± 2 kg) in each 
experimental period.
Diets
The experimental diets were prepared to meet the Norwegian 
nutrition recommendations [21], and formulated to meet 
energy the individual energy requirements for each partici-
pant as calculated from the self-reported food frequency 
questionnaire (FFQ) and using both the International (Har-
ris–Benedict equation) [22] and the Nordic energy require-
ment references [23]. Six energy levels were established for 
each diet (7500, 8300, 9600, 10,900, 12,200 and 13,500 kJ/
day). The experimental protein sources, covering 60% of 
total protein, the lean-seafood diet comprised cod, pollack, 
saithe and scallops, whereas the non-seafood diet comprised 
chicken breast filet without skin, lean beef, turkey breast 
filet without skin, pork, egg, low fat and skimmed milk (as 
ingredients in some of the meal recipes) and milk products 
(non-seafood diet). The remaining 40% of dietary protein 
was from vegetable and cereal sources. The experimental 
diets were balanced with equivalent amounts of dietary fibre, 
carbohydrates, protein, lipids, but not for cholesterol, which 
was higher for the non-seafood diet. Salt in both diets was 
restricted to a maximum of 5 g daily. Importantly, the par-
ticipants were instructed to not drink milk during any of 
the interventions, and only small amounts of dairy products 
were included in the non-seafood diet. In the lean-seafood 
diet, the only dairy product was small amount of butter in 
the diets twice a week. To fulfil the Nordic recommenda-
tion for calcium and vitamin D, the participants received 
750 mg calcium supplement during the lean-seafood inter-
vention and 500 mg calcium supplement during the non-
seafood intervention. For vitamin D, the participants daily 
received Vitamin  D3 (10 µg or 400 IU) supplement during 
the lean-seafood intervention [23]. The two experimental 
diets were presented as 7 day rotating menus, and the com-
position of energy and nutrients was determined by the Nor-
wegian Nutrient File database (“Kostholdsplanleggeren”) as 
shown in Table 1. The amino acid and the fatty acid com-
position, and examples of 1 day menus have been published 
previously [19]. Results from the analyses of Se in the lean-
seafood and non-seafood intervention meals correspond to 
average 97 and 56 µg/day, respectively. The corresponding 
figures for As were 1094 and 13 µg/day, respectively.
The participants prepared breakfasts, evening meals and 
snacks at home using an approved food list adjusted to their 
experimental diet and energy level, whereas lunches were 
prepared at the Western Norway University of Applied Sci-
ence and provided for the day after. During the weekdays, 
dinners were served at the Western Norway University of 
Applied Science, whereas weekend dinners were distributed 
on Fridays together with weekend and Monday lunches.
Biochemical analyses
Fasting morning spot urine was collected at day 1 and at 
the last day of each experimental period. The urine was 
aliquoted and stored at − 80 °C prior to analyses. Blood 
was drawn from the antecubital vein at the clinic after an 
overnight fast at the first and the last day of each experi-
mental period and EDTA plasma was prepared and stored 
at − 80 °C.
Urinary iodine and As concentrations [24], Se in 
plasma, and Se and As from the intervention meals [25, 
26] were determined by Inductive Coupled Plasma Mass 
Table 1   Mean acomposition of the 7 day experimental diets
Data are mean ± SD
DHA docosahexaenoic acids, EPA eicosapentaenoic acid, MUFA 
monounsatured fatty acids, PUFA polyunsaturated fatty acids, SFA 
saturated fatty acids, Se selenium
a Mean of the 7 day menu cycle for the 10,900 kJ diet, as determined 
by  the Norwegian nutrient file database (“Kostholdsplanleggeren”)
b The non-seafood dinner meals were supplemented with 3.3  g cod 
liver oil, containing 0.28 g EPA and 0.42 g DHA
Lean-seafood Non-seafood
Total energy (kJ) 10,882 ± 550 10,900 ± 452
Carbohydrates (% of energy) 52 ± 1 52 ± 1
Lipids (% of energy) 29 ± 1 29 ± 2
Protein (% of energy) 19 ± 1 19 ± 1
PUFA (g) 17 ± 5 17 ± 5
MUFA (g) 35 ± 5 35 ± 8
SFA (g) 25 ± 8 25 ± 3
EPA + DHA (g) 0.82 0.82b
Total fibre (g) 43 ± 4 43 ± 4
Iodine (µg) 828 ± 167 92 ± 29
Se (µg) 113 ± 18 54 ± 13
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Spectrometry (ICP-MS) by standardized procedures at Insti-
tute of Marine Research. For the determination of total Se 
and As in plasma, samples were diluted to a final volume of 
10 ml with deionized water. Prior to ICP-MS analyses [15], 
subsamples of 0.3 g were digested using 2.0 ml concentrated 
nitric acid (Merck, Darmstadt, Germany) and 0.50 ml 30% 
w/w hydrogen peroxide (Merck) in an Ethos Pro microwave 
system (Milestone, Sorisole, Italy). The technicians perform-
ing the analyses were blinded by giving the samples unique 
number codes.
Statistical analyses
Continuous variables are expressed as mean with standard 
deviation (SD), and median with 25th, 75th percentile. All 
residuals were normally disturbed, checked using histograms 
and normal probability (Q–Q) plots. The paired t test was 
used to compare variables within the intervention groups. 
Mixed-model linear regression analyses were used to ana-
lyse possible diet-effects on the outcomes from pre- to post-
intervention with the post-values as response and pre-values 
as covariate. The models were also adjusted for gender and/
or age, but did not differ from the unadjusted analyses (data 
not shown).
Two-tailed p < 0.05 was considered statistically signifi-
cant. Analyses were performed using the Statistical Package 
for the Social Sciences  (SPSS® Statistics Version 26).
Results
Characteristics of the participants
The mean ± SD age was 50.6 ± 15.3  years for all par-
ticipants (n = 20), 49.7 ± 18.6  years for males and 
51.0 ± 14.1  years for females. The average body 
weight and body mass index (BMI) was 86.3 ± 9.1 kg 
and 26.4 ± 3.0  kg/m2 in male, and 70.3 ± 7.0  kg, and 
25.3 ± 3.0 kg/m2 in female participants. Other character-
istics of the participants have been published previously 
[19].
Urinary iodine concentration
Pre- and post-intervention results of UIC by median (25th, 
75th percentile) within and between the interventions are 
given in Table 2 and Fig. 3. Median (25th, 75th percen-
tile) UIC was 70 (38, 110) and 79 (49, 94) µg/L in the 
lean-seafood and non-seafood intervention at baseline, 
respectively. 4 weeks of the lean-seafood intervention 
increased UIC to 135 (110, 278) µg/L (p < 0.001), whereas 
UIC was not significantly changed after the non-seafood 
intervention [58 (33, 91) µg/L, p = 0.077], but a significant 
diet-effect was observed (p < 0.001) (Table 2, Fig. 3). Six 
(30%) of the participants in the lean-seafood intervention 
had UIC values ≥ 100 µg/L at baseline, and 18 (90%) at 
post-intervention. The corresponding figures in the non-
seafood intervention were 4 (21%) at pre-intervention, and 
3 (16%) at post-intervention.
Plasma selenium
Pre- and post-intervention results of plasma Se by median 
(25th, 75th percentile) within and between the interven-
tions are given in Table 2 and Fig. 4. Fasting plasma Se 
increased significantly from median (25th, 75th percentile) 
70 (58, 73) µg/L to 75 (68, 85) µg/L (p < 0.001) in the 
lean-seafood intervention and decreased from 69 (63, 75) 
µg/L to 67 (60, 70) µg/L (p = 0.015) in the non-seafood 
intervention, and a significant diet-effect was observed 
(p = 0.001) (Table 2, Fig. 4).
Table 2   Urinary iodine and As concentrations and plasma Se and As concentrations in the subjects before and after 4 weeks interventions
As Arsenic, Se selenium, UIC urinary iodine concentration
a P for comparison within the intervention groups, paired sample t test
b P for comparison of diet effect between the intervention groups, mixed model regression analyses
Biochemical
parameters (µg/L)
Lean-seafood intervention (n = 20) Non-seafood intervention (n = 19)
Pre Post Pre Post









UIC 20 70 (38, 110) 135 (110, 278)  < 0.001 19 79 (49, 94) 58 (33, 91) 0.077  < 0.001
Plasma Se 19 70 (58, 73) 75 (68, 85)  < 0.001 17 69 (63, 75) 67 (60, 70) 0.015 0.001
Urinary As 20 62 (21, 180) 495 (300, 740) 0.002 19 48 (13, 96) 7 (5, 10) 0.059  < 0.001
Plasma As 19 5 (3, 8) 19 (9, 25) 0.001 17 4 (3, 11) 4 (3, 5) 0.651  < 0.001
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Urinary and plasma arsenic
Pre- and post-intervention results of fasting urinary and 
plasma As by median (25th, 75th percentile) within and 
between the interventions are given in Table 2 and Fig. 5 
and 6. Urinary As increased significantly from median 
(25th, 75th percentile) 62 (21, 180)  µg/L to 495 (300, 
740) µg/L (p = 0.002) in the lean-seafood intervention and 
was unchanged in the non-seafood intervention [from 48 
(13, 96) µg/L to 7 (5, 10) µg/L, p = 0.059], but a significant 
diet-effect was observed (p < 0.001) (Table 2, Fig. 5).
Plasma As increased significantly from median (25th, 
75th percentile) 5 (3, 8) µg/L to 19 (9, 25) µg/L (p = 0.001) 
in the lean-seafood intervention and was unchanged in 
the non-seafood intervention [from 4 (3, 11) µg/L to 4 (3, 
5) µg/L, p = 0.651], but a significant diet-effect was observed 
(p < 0.001) (Table 2, Fig. 6).
Fig. 3    Pre-and post-intervention results of the UIC in µg/L within 
and between the lean-seafood (n = 20) and non-seafood (n = 19) inter-
ventions. The horizontal line through the box represents the median. 
The lower boundary of the box is the 25th percentile and the upper 
bounder is the 75th percentile. The smallest and largest observed val-
ues within the distribution are represented by the horizontal at either 
end of the box. Outliers are marked with circles. P for comparison of 
diet-effect between the intervention groups, mixed model regression 
analyses < 0.001. UIC urinary iodine concentration
Fig. 4   Pre-and post-interven-
tion results of the plasma Se in 
µg/L within and between the 
lean-seafood (n = 19) and non-
seafood (n = 17) interventions. 
The horizontal line through 
the box represents the median. 
The lower boundary of the 
box is the 25th percentile and 
the upper bounder is the 75th 
percentile. The smallest and 
largest observed values within 
the distribution are represented 
by the horizontal at either end 
of the box. Outliers are marked 
with circles. P for comparison 
of diet-effect between the inter-
vention groups, mixed model 
regression analyses = 0.001. Se 
selenium
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Discussion
Lean-seafood has the highest natural iodine content, but 
evidence of a direct impact of increased intake of lean-
seafood on UIC is limited. We therefore aimed to measure 
UIC after intervention with lean-seafood and non-seafood 
in an intervention study with crossover design. The partici-
pant’s UIC was below the recommended median at base-
line, but after 4 weeks of the lean-seafood intervention 
median UIC was above 100 µg/L.
Fig. 5    Pre-and post-intervention results of the urinary As in µg/L 
within and between the lean-seafood (n = 20) and non-seafood 
(n = 19) interventions. The horizontal line through the box repre-
sents the median. The lower boundary of the box is the 25th percen-
tile and the upper bounder is the 75th percentile. The smallest and 
largest observed values within the distribution are represented by the 
horizontal at either end of the box. Outliers are marked with circles 
or asterisk (extreme points). P for comparison of diet-effect between 
the intervention groups, mixed model regression analyses < 0.001. As 
arsenic
Fig. 6    Pre-and post-intervention results of the plasma As in µg/L 
within and between the lean-seafood (n = 19) and non-seafood 
(n = 17) interventions. The horizontal line through the box repre-
sents the median. The lower boundary of the box is the 25th percen-
tile and the upper bounder is the 75th percentile. The smallest and 
largest observed values within the distribution are represented by the 
horizontal at either end of the box. Outliers are marked with circles 
or asterisk (extreme points). P for comparison of diet-effect between 
the intervention groups, mixed model regression analyses < 0.001. As 
arsenic
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The present investigation demonstrated that a 28 day 
lean-seafood intervention increased median UIC by 65 µg/L, 
whereas the UIC was unchanged after the non-seafood inter-
vention. Lean-seafood is a well-known source of iodine, 
but to our knowledge, this is the second intervention study 
directly demonstrating an effect of intake of lean-seafood 
on UIC. In a Norwegian 14 day semi-controlled study by 
Molin et al. [15], 38 participants were randomized into 
four groups for daily portions of 150 g cod, salmon, blue 
mussels or potato (control). The participants in the cod 
and blue mussel groups increased significantly their UIC 
from median 80–220 µg/L and 85–155 µg/L, respectively, 
compared to the control group with unchanged UIC from 
pre- to post-intervention (95 µg/L). Increases in UIC have 
also been demonstrated with cow milk [27], seaweed [28], 
and supplements [29]. Given the high iodine levels in lean-
seafood, our result was expected. Further, the historically 
good iodine status in the Icelandic population has, at least 
in part, been attributed to a high intake of fish [30, 31]. Still, 
although seafood is suggested to contribute to iodine status, 
UIC has been associated with intake of milk and dairy, and 
not seafood, in population-based studies from for example 
Iceland [32], Norway [33, 34], and Italy [35]. Additional, 
in a Danish crossover study including a random sample of 
inhabitants living in Alborg and Copenhagen, estimated 24 h 
UIC increased with increased seafood intake in participants 
living in Alborg, but not in Copenhagen, whereas increased 
milk intake was associated with increased UIC in both cit-
ies. However, even though the intake of seafood was above 
75 g/d in the group of Alborg participants who consumed 
most, the UIC was inadequate (median 71 µg/L), and ade-
quate UIC was detected only in those living in Copenhagen 
who consumed more than two glasses of milk daily [14]. 
Unlike seafood, with a recommended intake of 2–3 times 
a week, milk and dairy are often consumed daily. As UIC 
reflects intake of iodine the last 24 h, associations between 
seafood and UIC may be more difficult to detect, and there-
fore the overall contribution of seafood to iodine status may 
be underestimated.
At baseline, the median UIC was below 100 µg/L and 
hence, iodine status in the participants comprising 20 
healthy adult Norwegians may be considered suboptimal. 
The number of participants is small, but our finding that 
about 70% of the participants had UIC below 100 µg/L 
at study start corroborate the suggestion that iodine 
deficiency or sub-optimal iodine status is a re-emerging 
condition in Norway. For instance, recent studies have 
reported median UIC of 68 µg/L [3] and 85 µg/L [36] in 
pregnant women, and 75 µg/L in non-pregnant Norwegian 
women [37]. In addition, a small Norwegian cross-sec-
tional study detected inadequate UIC and iodine intake in 
elderly (62 µg/L), pregnant women (84 µg/L), non-preg-
nant women of childbearing age (71 µg/L), and in vegans 
(46 µg/L) [38]. Due to introduction of iodine fortification 
of cow fodder in the 1950s and traditionally high intake 
of milk and dairy with subsequent high iodine concen-
trations, health authorities used to consider Norwegians 
to be iodine-replete [39]. The possible re-emergence of 
sub-optimal iodine levels in Norway may be linked to the 
recorded declining intake of both milk, dairy and seafood 
[40].
Concomitant with increased UIC after the lean-seafood 
intervention, we also observed increased urinary As levels 
and increased fasting plasma As and Se levels, similar to the 
findings by Molin et al. [15]. These results were expected, as 
lean-seafood will also provide other essential nutrients, such 
as Se, as well as undesirable substances. Seafood consump-
tion is a predictor of elevated urinary As in several popula-
tion studies and may be used as a biomarker [41]. Seafood 
and cereals appear to be the most important contributor to 
adequate blood Se in adolescent Icelandic girls [42]. The 
relatively high content of As and other heavy metals, such as 
mercury (Hg), may be of concern. However, in lean-seafood 
the major As form is the arsenobetaine, considered to be 
non-toxic [43]. Several risk benefit evaluations of seafood 
have concluded that the beneficial effects of the essential 
nutrients in seafood outweighs potential harmful effects of 
undesirable substances, including mercury [44–46]. In this 
respect, the content of Se may be of particular importance. 
First, low Se intake is reported in several countries [47], and 
lean finfish species are good dietary sources for Se [16, 48]. 
Second, Se is also known to antagonize the toxic effects of 
heavy metals, including Hg [49], and a molar ratio of Se: Hg 
above 1.0 is suggested to provide protection against MeHg 
toxicity in humans [50].
The strengths of this study include the crossover design 
and the balanced diets and accurate recordings of the sea-
food intake. The UIC measured in spot urine samples is 
the recommended method [4], but it reflects recent dietary 
intake and there is debated whether this is the best estimate 
of measuring iodine status. Thus, it is a strength that the 
participants consumed lean-seafood daily. Milk and dairy 
are major sources for iodine. Importantly, only very small 
amounts of dairy products were included in the non-seafood 
diet and all participants were instructed to not drink milk 
during any of the interventions.
This study has some limitations. The diets with 60% of 
dietary proteins from lean-seafood or non-seafood sources 
does not reflect a normal dietary protein intake for most peo-
ple and the generalizability of our findings are thus limited. 
The comprehensive design limited the number of subjects 
willing to participate and led to a rather high drop-out (26%). 
This was, however, accounted for in the power analysis. The 
power calculation was, however, not based on UIC as the 
primary endpoint, but on cardiovascular lipid risk markers. 
Further, only Caucasians were included.
European Journal of Nutrition 
1 3
We conclude that 4 weeks of the lean-seafood interven-
tion increased UIC from sub-optimal levels to adequate lev-
els above 100 µg/L. Iodized salt programmes have had a high 
impact globally, but several European countries have not fol-
lowed this strategy and a sub-optimal iodine level is evident 
among subpopulations in Europe. Unlike iodized salt, iodine 
rich food items, such as lean-seafood will provide essential 
nutrients and undesirable substances, such as Se and As.
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